Enliven Therapeutics, Inc. - COM (ELVN)

Historical Institutional Holders from Q1 2023 to Q4 2024

All holders as of December 31, 2024
Q4 2024
Type / Class
Equity / COM
Shares, excl. options Q4 2024
49.6M
Holdings value Q4 2024
$1.12B
Value change Q4 2024
+$24.8M
Grand Portfolio weight change Q4 2024
+0%
Number of holders
109
Number of buys Q4 2024
57
Number of sells Q4 2024
-37
Average buys Q4 2024 %
+0%
Average sells Q4 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 49.6M $1.12B +$24.8M $22.50 109
2024 Q3 47.7M $1.22B -$20.8M $25.54 100
2024 Q2 48.3M $1.13B +$91.7M $23.37 92
2024 Q1 44.5M $781M +$95M $17.59 72
2023 Q4 39M $540M -$653K $13.84 61
2023 Q3 39.1M $534M -$2.18M $13.66 61
2023 Q2 39.1M $798M +$113M $20.41 61
2023 Q1 33.6M $735M +$735M $21.90 44